From Sphere Bio Apr 9 2025 Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today announced a significant expansion of its APAC distributor network. This development marks a key milestone in the Company's global commercial strategy to meet growing demand for its next-generation single-cell analysis platforms. Related Stories Sphere Fluidics appoints Edward Rayner as Non-Executive Director Sphere Bio's Expansion and Vision